Authors:
Doaa Khalil, Leslie Ngan Nguyen
MIT Supply Chain Management Program (SCM)
32
Summary:
Our project focuses on developing a next-generation risk management framework to proactively identify, assess, and mitigate long-term (3–7-year) risks in the cell therapy supply chain. Leveraging advanced technologies such as natural language processing (NLP), prediction-simulation modeling, and scenario planning, the framework aims to enhance operational resilience, support strategic decision-making, and ensure the reliable delivery of life-saving treatments.
